Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use

HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use

US Patent 9700606 · Granted Jul 11, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BTLA fusion protein agonists and uses thereof2024
Compositions and methods for treating autoimmune and inflammatory disorders2022
Modulation of immune response using BTLA agonist antibodies2022
CXCR3 receptor agonists2021
BTLA fusion protein agonists and uses thereof2021
Modulation of γδ T cells2020
Compositions and methods for treating autoimmune and inflammatory disorders2020
Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling act2019
Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling act2019
Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling act2019
Virus vaccination and treatment methods with OX40 agonist compositions2018
Compositions and methods for treating autoimmune and inflammatory disorders2018